Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 5 | |
Outperform | 5 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 9 analysts offering 12 month price targets for Dyne Therapeutics Inc have a median target of 53.00, with a high estimate of 66.00 and a low estimate of 50.00. The median estimate represents a 45.56% increase from the last price of 36.41.
High | 81.3% | 66.00 |
Med | 45.6% | 53.00 |
Low | 37.3% | 50.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Oct 28, 2024.
Average growth rate | +9.38% |
Average growth rate | -1.16% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼